BBIO BridgeBio Pharma, Inc.

NASDAQ
$81.50

BridgeBio Pharma, Inc. (BBIO) Institutional Ownership

What the institutions did with BBIO last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
532
filed a 13F this quarter
Managers holding
464
+11 on the quarter
Buyers
250
79 opened new
Sellers
234
68 sold out entirely
Buyer share
51.7%
of managers who traded it
Breadth
+3.3
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
Jupiter Topco LLC 14.1M 7.3%
Kohlberg Kravis Roberts & Co. L.P. 13.3M 6.9%
FARALLON CAPITAL MANAGEMENT, L.L.C. 10.7M 5.6%
BlackRock, Inc. 10.3M 5.3%
VIKING GLOBAL INVESTORS LP 9.9M 5.1%
VANGUARD CAPITAL MANAGEMENT LLC 7.9M 4.1%
VANGUARD PORTFOLIO MANAGEMENT LLC 7.7M 4.0%
WELLINGTON MANAGEMENT GROUP LLP 5.3M 2.7%
TWO SIGMA INVESTMENTS, LP 4.7M 2.4%
Aisling Capital Management LP 4.6M 2.4%
STATE STREET CORP 4.4M 2.3%
CITADEL ADVISORS LLC 3.8M 1.9%
Invesco Ltd. 3.7M 1.9%
D. E. Shaw & Co., Inc. 3.6M 1.9%
GEODE CAPITAL MANAGEMENT, LLC 3.4M 1.8%
JANE STREET GROUP, LLC 2.9M 1.5%
JPMORGAN CHASE & CO 2.4M 1.2%
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.3M 1.2%
FRANKLIN RESOURCES INC 2.2M 1.1%
Polar Capital Holdings Plc 2.1M 1.1%
FMR LLC 2.1M 1.1%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 2.0M 1.0%
SC US (TTGP), LTD. 1.9M 1.0%
GOLDMAN SACHS GROUP INC 1.8M 0.9%
UBS Group AG 1.8M 0.9%

Largest changes

Manager Action Previous Current Change
BlackRock, Inc. Reduced 14.2M 10.3M -3.9M
WELLINGTON MANAGEMENT GROUP LLP Increased 2.5M 5.3M +2.8M
PRICE T ROWE ASSOCIATES INC /MD/ Reduced 3.8M 1.7M -2.1M
Frazier Life Sciences Management, L.P. Reduced 3.4M 1.5M -1.9M
VIKING GLOBAL INVESTORS LP Reduced 11.8M 9.9M -1.9M
ADAGE CAPITAL PARTNERS GP, L.L.C. Increased 599.0K 2.3M +1.7M
TWO SIGMA INVESTMENTS, LP Increased 3.1M 4.7M +1.6M
Point72 Asset Management, L.P. New 0 1.5M +1.5M
GEODE CAPITAL MANAGEMENT, LLC Reduced 4.9M 3.4M -1.5M
FARALLON CAPITAL MANAGEMENT, L.L.C. Increased 9.4M 10.7M +1.4M
JANE STREET GROUP, LLC Increased 1.8M 2.9M +1.2M
Bellevue Group AG Increased 25.4K 1.2M +1.2M
Driehaus Capital Management LLC Sold Out 1.1M 0 -1.1M
D. E. Shaw & Co., Inc. Increased 2.5M 3.6M +1.1M
JPMORGAN CHASE & CO Increased 1.3M 2.4M +1.1M
HRT FINANCIAL LP Increased 71.9K 1.1M +1.0M
FIL Ltd Increased 88 1.0M +1.0M
Invesco Ltd. Reduced 4.6M 3.7M -891.9K
Balyasny Asset Management L.P. Increased 350.1K 1.2M +880.0K
Deep Track Capital, LP Sold Out 841.4K 0 -841.4K
Qube Research & Technologies Ltd New 0 727.2K +727.2K
PANAGORA ASSET MANAGEMENT INC Reduced 742.1K 25.9K -716.2K
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. Reduced 1.5M 829.8K -704.9K
Squarepoint Ops LLC Increased 556.3K 1.2M +635.4K
CITADEL ADVISORS LLC Increased 3.2M 3.8M +586.1K

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.